Kissei Pharmaceutical

• NCT06611696

  Collaborator, Phase 4, Recruiting, 160 people, 25 Sept 2024

• NCT02154347

  Phase 4, Completed, 178 people, 3 Jun 2014

• Refining the simplified frailty scale to improve the risk stratification of patients with multiple myeloma

  Fees or honoraria, 29 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov